ReNeuron is a global leader in cell-based therapeutics utilizing unique stem cell technologies to develop 'off the shelf' treatments targeting areas of significant unmet medical need. Our lead, developmental candidates target retinitis pigmentosa and chronic stroke disability. ReNeuron is incorporated in the UK, with offices in the UK and US.
1500 District Ave
Burlington, Massachusetts 01803